This site is intended for Healthcare Professionals.
EUA Fact Sheet Updates
Please be aware that Pfizer-BioNTech COVID-19 Vaccine is now available in three formulations. For additional information on differences across age groups and formulations please see Vaccine Formulations Guide on the home page of this website.
Label Update: Effective 31 Jan 2022
2.3 Vaccination Schedule
Pfizer-BioNTech COVID-19 Vaccine supplied in a multiple dose vial with a gray or purple cap and a label with a gray or purple border is authorised for use to provide:
• a single booster dose to individuals 18 years of age and older who have completed primary vaccination with another authorised or approved COVID-19 vaccine. The dosing interval for the heterologous booster dose is the same as that authorised for a booster dose of the vaccine used for primary vaccination
Click below to view:
• EUA Fact Sheet for Vaccination Providers - 12 year of age and older Dilute Before Use, Purple Cap
• EUA Fact Sheet for Vaccination Providers - 12 years of age and older Do Not Dilute, Gray Cap
• EUA Fact Sheet for Vaccination Providers - 5 through 11 years of age Dilute Before Use, Orange Cap
For healthcare professionals only